Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 209, 79-87
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01EB016721, R01CA195503, R01CA228133)
- AQH
- HGC
- NCI (5R21CA199295)
- National Cancer Institute (NIH F31CA196163)
- ArCS
This publication has 48 references indexed in Scilit:
- Regulation of Brain Tumor Dispersal by NKCC1 Through a Novel Role in Focal Adhesion RegulationPLOS Biology, 2012
- Non-viral gene delivery nanoparticles based on Poly(β-amino esters) for treatment of glioblastomaBiomaterials, 2011
- RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoNeuro-Oncology, 2011
- Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma GrowthJournal of Neuropathology & Experimental Neurology, 2011
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotypeProceedings of the National Academy of Sciences, 2011
- Neurosphere Culture and Human Organotypic Model to Evaluate Brain Tumor Stem Cells2009
- Intra-operatively obtained human tissue: Protocols and techniques for the study of neural stem cellsJournal of Neuroscience Methods, 2009
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesisProceedings of the National Academy of Sciences, 2009
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003